Skip to main content

precision medicine Archives

VUMC to help engage more study participants in research decisions

Oct. 25, 2023—The All of Us Engagement Core at Vanderbilt University Medical Center is helping make human research more equitable, inclusive and stronger to accelerate the prevention and treatment of illness through genomic and precision medicine.

Read more


Roden honored for his leadership in precision medicine

Jan. 12, 2023—Vanderbilt's Dan Roden, MD, will receive the PMWC 2023 Pioneer Award Jan. 27 during this year’s Precision Medicine World Conference.

Read more


Anti-nausea drug response in children

Jan. 10, 2023—Genetic variation in a metabolic enzyme was not associated with response to the anti-nausea drug odansetron in children, Vanderbilt researchers report.

Read more


Grant creates center for maternal, pediatric precision therapeutics

Sep. 17, 2021—Vanderbilt University Medical Center has been awarded a five-year, $6 million grant from the National Institutes of Health to serve as a center of excellence for Maternal and Pediatric Precision in Therapeutics.

Read more


VUMC team to test personalized acute heart failure treatment

Sep. 16, 2021—Researchers at Vanderbilt have been awarded a five-year, $4 million federal grant to test whether a personalized medicine strategy will improve outcomes for patients hospitalized with acute heart failure.

Read more


All of Us program launches cloud-based research platform

Jun. 18, 2020—On May 27, the All of Us Research Program launched the beta version of its cloud-based research platform, the Researcher Workbench.

Read more


VUMC’s Denny selected to lead national ‘All of Us’ program

Dec. 11, 2019—The National Institutes of Health (NIH) has selected Joshua Denny, MD, MS, vice president of Personalized Medicine at Vanderbilt University Medical Center, to be the chief executive officer of the federal All of Us Research Program.

Read more


Study shines light on architecture of kidney disease

Sep. 25, 2019—A study of 280,000 U.S. veterans, including 56,000 African Americans, has identified in greater detail than ever before the genetic architecture of kidney function and chronic kidney disease (CKD), according to researchers at Vanderbilt University Medical Center and their colleagues.

Read more


Achilles’ heel for kidney cancer

Feb. 28, 2019—The discovery that kidney cells with mutations in a certain gene are sensitive to therapies called PI3K inhibitors opens new opportunities for applying precision medicine to cancer treatment.

Read more


Investigators map genomic landscape of very rare cancer

Feb. 28, 2019—A team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tricholemmal tumor and identified a targeted treatment for this very rare cancer.

Read more


Grant supports novel imaging initiative to enhance cancer care

Jan. 31, 2019—A Vanderbilt initiative to develop predictive imaging technologies that clinicians can use to better match patients with personalized care has received National Cancer Institute (NCI) funding.

Read more


Ethics study explores precision medicine’s risks, rewards

Nov. 29, 2018—Precision medicine research — which involves the consolidation of massive amounts of complex data and the widespread sharing of those data for a variety of research studies — offers the prospect of both benefit and harm.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more